Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

Detalles Bibliográficos
Autores principales: Klok, Frederikus A., Versteeg, Henri H., Verschoor, Arie J., Huisman, Menno V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461990/
https://www.ncbi.nlm.nih.gov/pubmed/30696981
http://dx.doi.org/10.1038/s41416-018-0361-x
_version_ 1783410561917124608
author Klok, Frederikus A.
Versteeg, Henri H.
Verschoor, Arie J.
Huisman, Menno V.
author_facet Klok, Frederikus A.
Versteeg, Henri H.
Verschoor, Arie J.
Huisman, Menno V.
author_sort Klok, Frederikus A.
collection PubMed
description
format Online
Article
Text
id pubmed-6461990
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64619902020-01-30 Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis' Klok, Frederikus A. Versteeg, Henri H. Verschoor, Arie J. Huisman, Menno V. Br J Cancer Correspondence Nature Publishing Group UK 2019-01-30 2019-02-19 /pmc/articles/PMC6461990/ /pubmed/30696981 http://dx.doi.org/10.1038/s41416-018-0361-x Text en © Cancer Research UK 2019 https://creativecommons.org/licenses/by/4.0/Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Correspondence
Klok, Frederikus A.
Versteeg, Henri H.
Verschoor, Arie J.
Huisman, Menno V.
Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_full Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_fullStr Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_full_unstemmed Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_short Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
title_sort comment on 'd-dimer and high-sensitivity c-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461990/
https://www.ncbi.nlm.nih.gov/pubmed/30696981
http://dx.doi.org/10.1038/s41416-018-0361-x
work_keys_str_mv AT klokfrederikusa commentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT versteeghenrih commentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT verschoorariej commentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis
AT huismanmennov commentonddimerandhighsensitivitycreactiveproteinlevelstopredictvenousthromboembolismrecurrenceafterdiscontinuationofanticoagulationforcancerassociatedthrombosis

Ejemplares similares